5 (Based on Intent to Use) Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances or the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; diagnostic agents, preparations, substances and diagnostic materials in the form of preparations for medical purposes; imaging agents for positron emission tomography (PET) imaging for delivery of materials to target sites within the body for diagnostic purposes; imaging agents for positron emission tomography (PET) imaging for use in detecting disease, namely, radio tracers for positron emission tomography (PET) imaging
Trademark: 90747075
